TY - JOUR
T1 - Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019: A Prospective Cohort Study of 46 000 Healthcare Workers
AU - Kristensen, Jonas Henrik
AU - Hasselbalch, Rasmus Bo
AU - Pries-Heje, Mia
AU - Nielsen, Pernille Brok
AU - Dehlbæk Knudsen, Andreas
AU - Fogh, Kamille
AU - Boesgaard Norsk, Jakob
AU - Eiken, Aleksander
AU - Andersen, Ove
AU - Fischer, Thea Kølsen
AU - Juul Jensen, Claus Antonio
AU - Torp-Pedersen, Christian
AU - Rungby, Jørgen
AU - Ditlev, Sisse Bolm
AU - Hageman, Ida
AU - Møgelvang, Rasmus
AU - Gybel-Brask, Mikkel
AU - Dessau, Ram Benny
AU - Sørensen, Erik
AU - Harritshøj, Lene
AU - Folke, Fredrik
AU - Engel Møller, Maria Elizabeth
AU - Benfield, Thomas
AU - Ullum, Henrik
AU - Jørgensen, Charlotte Sværke
AU - Rye Ostrowski, Sisse
AU - Nielsen, Susanne Dam
AU - Bundgaard, Henning
AU - Iversen, Kasper
N1 - © The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
PY - 2022/7
Y1 - 2022/7
N2 - BACKGROUND: The purpose of this study was to assess whether influenza vaccination has an impact on the risk of coronavirus disease 2019 (COVID-19).METHODS: A cohort of 46 112 healthcare workers were tested for antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and filled in a survey on COVID-19 symptoms, hospitalization, and influenza vaccination.RESULTS: The risk ratio of hospitalization due to SARS-CoV-2 for influenza vaccinated compared with unvaccinated participants was 1.00 for the seasonal vaccination in 2019/2020 (confidence interval, .56-1.78, P = 1.00). Likewise, no clinical effect of influenza vaccination on development of antibodies against SARS-CoV-2 was found.CONCLUSIONS: The present findings indicate that influenza vaccination does not affect the risk of SARS-CoV-2 infection or COVID-19.
AB - BACKGROUND: The purpose of this study was to assess whether influenza vaccination has an impact on the risk of coronavirus disease 2019 (COVID-19).METHODS: A cohort of 46 112 healthcare workers were tested for antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and filled in a survey on COVID-19 symptoms, hospitalization, and influenza vaccination.RESULTS: The risk ratio of hospitalization due to SARS-CoV-2 for influenza vaccinated compared with unvaccinated participants was 1.00 for the seasonal vaccination in 2019/2020 (confidence interval, .56-1.78, P = 1.00). Likewise, no clinical effect of influenza vaccination on development of antibodies against SARS-CoV-2 was found.CONCLUSIONS: The present findings indicate that influenza vaccination does not affect the risk of SARS-CoV-2 infection or COVID-19.
UR - http://www.scopus.com/inward/record.url?scp=85137407540&partnerID=8YFLogxK
U2 - 10.1093/infdis/jiac001
DO - 10.1093/infdis/jiac001
M3 - Journal article
C2 - 34989811
VL - 226
SP - 6
EP - 10
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
SN - 0022-1899
IS - 1
M1 - jiac001
ER -